TABLE 1.
Total | CVD type | Combined | Men (M) | Women (W) | M vs. W | |||
n | Mean ± SDa | n | Mean ± SD | n | Mean ± SD | P-valueb | ||
Age |
n = 1,346 Mean 61.4 ± 16.8 Range 18–91 |
Con (n = 234) | 64.7 @ 11.8 | 116 | 65.8 @ 12.7 | 118 | 63.6 @ 10.9 | 0.29 |
Myo (n = 303) | 40.1 @ 14.6 | 237 | 38.4 @ 13.6 | 66 | 46.4 @ 16.3 | 0.0002 | ||
Card (n = 293) | 67.1 @ 11.4 | 182 | 68 @ 11.6 | 111 | 65.4 @ 10.9 | 0.26 | ||
CAD (n = 239) | 67.2 @ 12.5 | 115 | 67.1 @ 12.8 | 124 | 67.4 @ 12.3 | 0.99 | ||
MI (n = 159) | 68.5 @ 10.5 | 121 | 69.3 @ 9.6 | 38 | 65.9 @ 12.7 | 0.35 | ||
CHF (n = 286) | 70 @ 10.7 | 166 | 70.9 @ 9.8 | 120 | 68.8 @ 11.7 | 0.35 | ||
BMI |
n = 1,023 Mean 29.2 ± 6 |
Con (n = 226) | 27.4 @ 4.7 | 113 | 28.1 @ 4.5 | 113 | 26.7 @ 4.9 | 0.052 |
Myo (n/a) | − | − | − | − | − | − | ||
Card (n = 290) | 29.3 @ 6.2 | 179 | 29.7 @ 5.4 | 111 | 28.8 @ 7.3 | 0.73 | ||
CAD (n = 233) | 29.3 @ 6.2 | 112 | 29.9 @ 4.9 | 121 | 28.8 @ 6.8 | 0.58 | ||
MI (n = 156) | 29.7 @ 6 | 118 | 29.5 @ 4.9 | 38 | 30.2 @ 8.6 | 0.983 | ||
CHF (n = 281) | 30.6 @ 6.5 | 161 | 30.7 @ 5.7 | 120 | 30.4 @ 7.4 | 0.99 | ||
LVEF% |
n = 1,086 Mean 54.7 ± 15.1 |
Con (n/a) | − | − | − | − | − | − |
Myo (n = 283) | 48.4 @ 20.3 | 220 | 48.4 @ 20.3 | 60 | 48.3 @ 20.6 | 0.99 | ||
Card (n = 293) | 53 @ 14.1 | 182 | 51.1 @ 13.9 | 111 | 56.2 @ 13.9 | 0.013 | ||
CAD (n = 237) | 62.1 @ 7.4 | 115 | 61.4 @ 8.4 | 122 | 62.8 @ 6.4 | 0.55 | ||
MI (n = 158) | 53.1 @ 11.6 | 120 | 52.3 @ 11.9 | 38 | 55.6 @ 10.4 | 0.49 | ||
CHF (n = 286) | 52.4 @ 13.8 | 166 | 48.8 @ 13.6 | 120 | 57.4 @ 12.4 | <0.000001 |
aBMI, body mass index; CAD, coronary artery disease; Card, cardiomyopathy; CHF, congestive heart failure; Con, control; CVD, cardiovascular disease; M, men; MI, myocardial infarction; Myo, myocarditis; n/a, not available; LVEF, left ventricle ejection fraction; SD, standard deviation; W, women. bP-values with significance < 0.05 indicated in bold font.